Should you buy Affymax stock? (Other OTC:AFFY). Let's see how it does in our automated value investing analysis system.
Advantages | Disadvantages | Neutral |
---|---|---|
|
|
|
AFFY Price (Affymax stock price per share) |
$0.01 | |
PE Ratio versus Sector | 99% lower than other Healthcare stocks | |
PE Ratio versus Industry | 99% lower than other Biotechnology stocks | |
Cash Yield | -1189.52% |
Based on our analysis, we believe that you should not buy Affymax right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Does Affymax have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles
Stock Brokers and Investment Brokers
Should You Invest in Insurance Stocks?
Should You Sell Stocks in December?
What is Portfolio Rebalancing?
What is Self-Directed Investing?
Is There a Secret Formula to Pick Good Stocks?
What is the Difference Between Trading Stocks and Investing?